美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

REIN THERAPEUTICS INC

1.21

+0.09008.04%

盤後：1.210.00000.00%18:25 EST

成交量：8.17萬

成交額：9.82萬

市值：3,180.65萬

市盈率：-0.48

高：1.28

開：1.09

低：1.09

收：1.12

52周最高：2.96

52周最低：1.02

股本：2,628.64萬

流通股本：2,235.40萬

量比：1.22

換手率：0.37%

股息：- -

股息率：- -

每股收益(TTM):-2.5002

每股收益(LYR):-3.5054

淨資產收益率：-83.28%

總資產收益率：-18.81%

市淨率：26.84

市盈率(LYR):-0.35

資料載入中...

總覽公司新聞資訊公告

Rein Therapeutics, Inc.盤中異動急速上漲6.98%報1.38美元

Rein Therapeutics, Inc.盤中異動快速下挫7.44%報1.12美元

BUZZ--美國股票走勢-Netflix、ServiceNow、D.R. Horton

BUZZ--美國股票走勢-Netflix、ServiceNow、D.R. Horton

BUZZ-治療肺部疤痕疾病的藥物獲得歐盟孤兒藥地位，Rein Therapeutics 股價上漲

Rein Therapeutics：決定終止與Yorkville於7月29日簽署的備用股權購買協議

REIN THERAPEUTICS INC：決定終止與Ya Ii Pn簽訂的7月29日預付協議 - SEC備案

REIN THERAPEUTICS INC：因選擇終止Ppa和Sepa協議未產生罰款或費用

Rein Therapeutics發布新科學出版物，表明Lti-03可能減少肺部疤痕並保護肺修復所需細胞

REIN THERAPEUTICS INC獲得FDA批准恢復在美國進行Lti-03的第二階段試驗

Rein Therapeutics獲得歐洲監管部門批准，啓動Lti-03治療特發性肺纖維化的二期臨牀試驗

REIN THERAPEUTICS INC - FDA建議公司提交完整回應函處理修訂研究報告及相關説明 - SEC文件

REIN THERAPEUTICS INC向SEC提交招股説明書，涉及銷售股東出售最多1000萬股普通股

Rein Therapeutics向SEC提交招股説明書擬出售多達1000萬股普通股

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/RNTX/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RNTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNTX\",,,,,undefined,":{"symbol":"RNTX","market":"US","secType":"STK","nameCN":"REIN THERAPEUTICS INC","latestPrice":1.21,"timestamp":1771621200000,"preClose":1.12,"halted":0,"volume":81719,"hourTrading":{"tag":"盘后","latestPrice":1.21,"preClose":1.21,"latestTime":"18:25 EST","volume":112,"amount":135.52,"timestamp":1771629936835,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.08035714285714272,"floatShares":22354000,"shares":26286382,"eps":-2.500246,"marketStatus":"休市中","change":0.09,"latestTime":"02-20 16:00:00 EST","open":1.09,"high":1.28,"low":1.09,"amount":98160.7647372,"amplitude":0.169643,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.500246,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"listingDate":1498708800000,"exchange":"NASDAQ","adjPreClose":1.12,"preHourTrading":{"tag":"盘前","latestPrice":1.12,"preClose":1.12,"latestTime":"08:54 EST","volume":638,"amount":714.5600000000001,"timestamp":1771595659722,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.21,"preClose":1.21,"latestTime":"18:25 EST","volume":112,"amount":135.52,"timestamp":1771629936835,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.2162845982663015},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNTX\",,,,,undefined,":{"symbol":"RNTX","floatShares":22354000,"roa":"-18.81%","roe":"-83.28%","lyrEps":-3.505399,"volumeRatio":1.2162845982663015,"shares":26286382,"dividePrice":0,"high":1.28,"amplitude":0.169643,"preClose":1.12,"low":1.09,"week52Low":1.02,"pbRate":"26.84","week52High":2.96,"institutionHeld":0,"latestPrice":1.21,"eps":-2.500246,"divideRate":0,"volume":81719,"delay":0,"ttmEps":-2.500246,"open":1.09,"prevYearClose":1.16,"prevWeekClose":1.12,"prevMonthClose":1.3,"prevQuarterClose":1.16,"fiveDayClose":1.17,"twentyDayClose":1.34,"sixtyDayClose":1.48},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RNTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"RNTX","fiscalQuarterEnding":"2025/09","expectedEps":-0.24,"name":null,"time":"盤後","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":-0.21},{"market":"US","date":"2025-08-14","symbol":"RNTX","fiscalQuarterEnding":"2025/06","expectedEps":-0.22,"name":null,"time":"盤後","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.28},{"market":"US","date":"2025-05-15","symbol":"RNTX","fiscalQuarterEnding":"2025/03","expectedEps":-0.21,"name":null,"time":"盤後","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.25},{"market":"US","date":"2025-04-07","symbol":"RNTX","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1743998400000,"reportTimeType":"post","actualEps":-0.26},{"market":"US","date":"2024-11-14","symbol":"RNTX","fiscalQuarterEnding":"2024/09","expectedEps":-0.25,"name":null,"time":"盤後","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.27}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RNTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RNTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1769058000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RNTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RNTX","date":"2026-02-20","current":-0.483952,"percent":0.797101,"low":-2.000549,"twenty":-1.259605,"median":-0.58056,"eighty":-0.49997,"high":-0.401342,"avg":-0.765175,"sd":0.411736,"marketCap":29440747},"quantilePoints":[{"date":"2025-01-17","current":-1.459659,"twenty":-1.48337,"median":-1.467068,"eighty":-1.447804,"marketCap":42681903},{"date":"2025-01-24","current":-1.630077,"twenty":-1.576729,"median":-1.478183,"eighty":-1.446322,"marketCap":47665070},{"date":"2025-01-31","current":-1.467069,"twenty":-1.741219,"median":-1.496707,"eighty":-1.462623,"marketCap":42898563},{"date":"2025-02-07","current":-1.704171,"twenty":-1.704171,"median":-1.526344,"eighty":-1.459659,"marketCap":49831664},{"date":"2025-02-14","current":-1.741218,"twenty":-1.704171,"median":-1.578211,"eighty":-1.462623,"marketCap":50914961},{"date":"2025-02-21","current":-1.98573,"twenty":-1.794566,"median":-1.630077,"eighty":-1.468551,"marketCap":58064721},{"date":"2025-02-28","current":-1.533754,"twenty":-1.79753,"median":-1.630077,"eighty":-1.47596,"marketCap":44848497},{"date":"2025-03-07","current":-1.467069,"twenty":-1.753073,"median":-1.607848,"eighty":-1.468551,"marketCap":42898563},{"date":"2025-03-14","current":-1.496707,"twenty":-1.741218,"median":-1.552277,"eighty":-1.467069,"marketCap":43765200},{"date":"2025-03-21","current":-1.430022,"twenty":-1.733809,"median":-1.518935,"eighty":-1.461141,"marketCap":41815266},{"date":"2025-03-28","current":-1.311471,"twenty":-1.704171,"median":-1.507821,"eighty":-1.431504,"marketCap":38348715},{"date":"2025-04-04","current":-1.259605,"twenty":-1.704171,"median":-1.496707,"eighty":-1.416685,"marketCap":36832099},{"date":"2025-04-11","current":-0.545587,"twenty":-1.696762,"median":-1.481888,"eighty":-1.32629,"marketCap":34308123},{"date":"2025-04-17","current":-0.577063,"twenty":-1.667124,"median":-1.474478,"eighty":-1.296652,"marketCap":36287438},{"date":"2025-04-25","current":-0.640015,"twenty":-1.630077,"median":-1.467069,"eighty":-1.259605,"marketCap":40246068},{"date":"2025-05-02","current":-0.573565,"twenty":-1.630077,"median":-1.459659,"eighty":-0.64701,"marketCap":36067514},{"date":"2025-05-09","current":-0.601544,"twenty":-1.630077,"median":-1.437431,"eighty":-0.622528,"marketCap":37826905},{"date":"2025-05-16","current":-0.825375,"twenty":-1.622667,"median":-1.430022,"eighty":-0.622528,"marketCap":51902033},{"date":"2025-05-23","current":-0.696336,"twenty":-1.607848,"median":-1.415203,"eighty":-0.629523,"marketCap":42665230},{"date":"2025-05-30","current":-0.696336,"twenty":-1.584138,"median":-1.407793,"eighty":-0.629523,"marketCap":42665230},{"date":"2025-06-06","current":-0.705061,"twenty":-1.560428,"median":-1.311471,"eighty":-0.635119,"marketCap":43199785},{"date":"2025-06-13","current":-0.712292,"twenty":-1.550055,"median":-1.296652,"eighty":-0.639316,"marketCap":43642859},{"date":"2025-06-20","current":-0.592974,"twenty":-1.539682,"median":-1.259605,"eighty":-0.638616,"marketCap":36332127},{"date":"2025-06-27","current":-0.524276,"twenty":-1.524863,"median":-1.24849,"eighty":-0.622528,"marketCap":32122917},{"date":"2025-07-03","current":-0.54597,"twenty":-1.518935,"median":-0.809312,"eighty":-0.609134,"marketCap":33452141},{"date":"2025-07-11","current":-0.535123,"twenty":-1.515971,"median":-0.771713,"eighty":-0.598047,"marketCap":32787529},{"date":"2025-07-18","current":-0.506198,"twenty":-1.508562,"median":-0.726755,"eighty":-0.578462,"marketCap":31015230},{"date":"2025-07-25","current":-0.513429,"twenty":-1.504116,"median":-0.717873,"eighty":-0.562281,"marketCap":31458305},{"date":"2025-08-01","current":-0.421229,"twenty":-1.501152,"median":-0.708677,"eighty":-0.556817,"marketCap":25809102},{"date":"2025-08-08","current":-0.417509,"twenty":-1.496707,"median":-0.703515,"eighty":-0.543648,"marketCap":25581194},{"date":"2025-08-15","current":-0.434435,"twenty":-1.490779,"median":-0.698131,"eighty":-0.532953,"marketCap":26618269},{"date":"2025-08-22","current":-0.445213,"twenty":-1.481888,"median":-0.696336,"eighty":-0.524276,"marketCap":26334772},{"date":"2025-08-29","current":-0.445213,"twenty":-1.478924,"median":-0.689114,"eighty":-0.516321,"marketCap":26334772},{"date":"2025-09-05","current":-0.537801,"twenty":-1.474478,"median":-0.673872,"eighty":-0.514875,"marketCap":31811472},{"date":"2025-09-12","current":-0.425513,"twenty":-1.472996,"median":-0.650825,"eighty":-0.513429,"marketCap":25169516},{"date":"2025-09-19","current":-0.453092,"twenty":-1.467069,"median":-0.643512,"eighty":-0.506198,"marketCap":26800874},{"date":"2025-09-26","current":-0.470822,"twenty":-1.467069,"median":-0.629523,"eighty":-0.496939,"marketCap":27849604},{"date":"2025-10-03","current":-0.457032,"twenty":-1.465587,"median":-0.622528,"eighty":-0.470507,"marketCap":27033925},{"date":"2025-10-10","current":-0.539771,"twenty":-1.459659,"median":-0.615534,"eighty":-0.469167,"marketCap":31927997},{"date":"2025-10-17","current":-0.504312,"twenty":-1.455213,"median":-0.601544,"eighty":-0.470507,"marketCap":29830538},{"date":"2025-10-24","current":-0.496432,"twenty":-1.437431,"median":-0.598047,"eighty":-0.472004,"marketCap":29364436},{"date":"2025-10-31","current":-0.61069,"twenty":-1.435949,"median":-0.596299,"eighty":-0.477169,"marketCap":36122917},{"date":"2025-11-07","current":-0.61463,"twenty":-1.430022,"median":-0.598047,"eighty":-0.479267,"marketCap":36355968},{"date":"2025-11-14","current":-0.531891,"twenty":-1.430022,"median":-0.598047,"eighty":-0.480672,"marketCap":31461895},{"date":"2025-11-21","current":-0.616035,"twenty":-1.42854,"median":-0.59455,"eighty":-0.480672,"marketCap":36275207},{"date":"2025-11-28","current":-0.700851,"twenty":-1.422612,"median":-0.598047,"eighty":-0.480672,"marketCap":41269619},{"date":"2025-12-05","current":-0.620499,"twenty":-1.415203,"median":-0.603206,"eighty":-0.482843,"marketCap":36538070},{"date":"2025-12-12","current":-0.687459,"twenty":-1.415203,"median":-0.607107,"eighty":-0.492492,"marketCap":40481028},{"date":"2025-12-19","current":-0.575859,"twenty":-1.407793,"median":-0.606928,"eighty":-0.496432,"marketCap":33909432},{"date":"2025-12-26","current":-0.589251,"twenty":-1.390011,"median":-0.606928,"eighty":-0.496432,"marketCap":34698024},{"date":"2026-01-02","current":-0.517826,"twenty":-1.341109,"median":-0.603755,"eighty":-0.496432,"marketCap":30492203},{"date":"2026-01-09","current":-0.54461,"twenty":-1.311471,"median":-0.601544,"eighty":-0.497777,"marketCap":32069386},{"date":"2026-01-16","current":-0.517826,"twenty":-1.30258,"median":-0.596299,"eighty":-0.498849,"marketCap":30492203},{"date":"2026-01-23","current":-0.598179,"twenty":-1.296652,"median":-0.593762,"eighty":-0.499215,"marketCap":35223751},{"date":"2026-01-30","current":-0.638355,"twenty":-1.293688,"median":-0.598047,"eighty":-0.499741,"marketCap":37589526},{"date":"2026-02-06","current":-0.508898,"twenty":-1.277387,"median":-0.593762,"eighty":-0.500131,"marketCap":29966475},{"date":"2026-02-13","current":-0.52229,"twenty":-1.259605,"median":-0.589251,"eighty":-0.501948,"marketCap":30755066},{"date":"2026-02-20","current":-0.49997,"twenty":-1.259605,"median":-0.58056,"eighty":-0.49997,"marketCap":29440747}],"updateTime":1771768360958},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RNTX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608804008","title":"Rein Therapeutics, Inc.盤中異動 急速上漲6.98%報1.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608804008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608804008?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 00:23","pubTimestamp":1770135837,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日00时23分，Rein Therapeutics, Inc.股票出现异动，股价快速上涨6.98%。Rein Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Liminatus Pharma Inc C/Wts 30/04/2030 、Jasper Therapeutics Inc C/Wts 24/09/2026 、Liminatus Pharma, Inc.涨幅较大，Cdt Equity Inc.、Pmgc Holdings Inc.、Liminatus Pharma, Inc.较为活跃，换手率分别为650.41%、596.30%、55.11%，振幅较大的相关个股有Liminatus Pharma Inc C/Wts 30/04/2030 、Jasper Therapeutics Inc C/Wts 24/09/2026 、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为70.33%、68.89%、47.28%。Rein Therapeutics, Inc.公司简介：Rein Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204002357a6cf3b0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204002357a6cf3b0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4139","BK4007","RNTX"],"gpt_icon":0},{"id":"2604114004","title":"Rein Therapeutics, Inc.盤中異動 快速下挫7.44%報1.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604114004","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604114004?lang=zh_tw&edition=fundamental","pubTime":"2026-01-20 22:30","pubTimestamp":1768919426,"startTime":"0","endTime":"0","summary":"北京时间2026年01月20日22时30分，Rein Therapeutics, Inc.股票出现波动，股价大幅跳水7.44%。截至发稿，该股报1.12美元/股，成交量12.4943万股，换手率0.48%，振幅3.31%。Rein Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Corvus Pharmaceuticals, Inc.、Rapt Therapeutics, Inc.、Immunitybio, Inc.涨幅较大，Jaguar Health, Inc.、Dermata Therapeutics, Inc.、Rapt Therapeutics, Inc.较为活跃，换手率分别为47.56%、45.96%、37.68%，振幅较大的相关个股有Matinas Biopharma Holdings, Inc.、Galecto, Inc.、Impact Biomedical, Inc.，振幅分别为6.78%、4.00%、3.54%。Rein Therapeutics, Inc.公司简介：Rein Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120223027a44180b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120223027a44180b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RNTX","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2604191361","title":"BUZZ--美國股票走勢-Netflix、ServiceNow、D.R. Horton","url":"https://stock-news.laohu8.com/highlight/detail?id=2604191361","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604191361?lang=zh_tw&edition=fundamental","pubTime":"2026-01-20 22:12","pubTimestamp":1768918352,"startTime":"0","endTime":"0","summary":"nL6N3YE109 ** BioXcel Therapeutics Inc BTAI.O:BUZZ - 寻求美国食品和药物管理局批准家用激动疗法；股价下跌   nL4N3YL11K ** Netflix Inc NFLX.O:BUZZ - 上涨；提交对华纳兄弟的全现金修正报价   nL4N3YL0TJ ** StandardAero Inc SARO.N:BUZZ - 在纳入标准普尔中型股之前上涨   nL6N3YL0M1 ** Novavax Inc NVAX.O:BUZZ - 与辉瑞签署疫苗开发许可协议后上涨   nL4N3YL13N ** Invivyd Inc IVVD.O:BUZZ - 将推出针对长期COVID、疫苗相关疾病的抗体试验；股价下跌   nL4N3YL14D ** ServiceNow Inc NOW.N:BUZZ - 因报道软件公司与 OpenAI 签订协议而上涨   nL4N3YL16C ** Fastenal Co FAST.O:BUZZ - 因第四季度营收不及预期而下跌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nL4S3YL1CO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CEG","IE00BFXG0V08.USD","CDW","LU0006306889.USD","IE00B19Z9505.USD","LU0690374961.EUR","BK4575","LU0690374615.EUR","NEM","TLN","NVAX","FCEL","IE00BKVL7J92.USD","PM","LU0965509283.SGD","ONDS","USAW.SI","LU0170899867.USD","BK4612","DHI","LU2087625088.SGD","BK4613","PFE","LU0061474960.USD","RNTX","NOW","VST","BK4579","WBD","TOST","AMZN","BTAI","LU1548497426.USD","IBRX","INTC","SARO","LU1814569148.SGD","LU1691799644.USD","LU0683600562.USD","MMM","NRG","NTAP","NFLX","IVVD","RAPT","FAST","ALHC","LU1267930573.SGD","CRML"],"gpt_icon":0},{"id":"2604119139","title":"BUZZ--美國股票走勢-Netflix、ServiceNow、D.R. Horton","url":"https://stock-news.laohu8.com/highlight/detail?id=2604119139","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604119139?lang=zh_tw&edition=fundamental","pubTime":"2026-01-20 22:12","pubTimestamp":1768918352,"startTime":"0","endTime":"0","summary":"nL6N3YE109 ** BioXcel Therapeutics Inc BTAI.O:BUZZ - 寻求美国食品和药物管理局批准家用激动疗法；股价下跌   nL4N3YL11K ** Netflix Inc NFLX.O:BUZZ - 上涨；提交对华纳兄弟的全现金修正报价   nL4N3YL0TJ ** StandardAero Inc SARO.N:BUZZ - 在纳入标准普尔中型股之前上涨   nL6N3YL0M1 ** Novavax Inc NVAX.O:BUZZ - 与辉瑞签署疫苗开发许可协议后上涨   nL4N3YL13N ** Invivyd Inc IVVD.O:BUZZ - 将推出针对长期COVID、疫苗相关疾病的抗体试验；股价下跌   nL4N3YL14D ** ServiceNow Inc NOW.N:BUZZ - 因报导软件公司与 OpenAI 签订协议而上涨   nL4N3YL16C ** Fastenal Co FAST.O:BUZZ - 因第四季度营收不及预期而下跌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nL4T3YL1CO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRG","NOW","PM","LU0345769631.USD","BTAI","LU1868837300.USD","IE00BMPRXN33.USD","SG9999001176.USD","FCEL","BK4088","PFE","CEG","LU1861558580.USD","LU2125909247.SGD","MMM","ALHC","NEM","NTAP","TOST","NFLX","IE00BLSP4239.USD","SG9999001077.SGD","IVVD","LU1069344957.HKD","LU1244550577.SGD","LU0477156953.USD","LU0345770993.USD","CDW","RAPT","LU0672654240.SGD","LU1923623000.USD","IE00BWXC8680.SGD","LU1951198990.SGD","TLN","USAW.SI","DHI","LU1951200564.SGD","NVAX","WBD","LU0345780521.USD","SARO","RNTX","FAST"],"gpt_icon":1},{"id":"2604311524","title":"BUZZ-治療肺部疤痕疾病的藥物獲得歐盟孤兒藥地位，Rein Therapeutics 股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2604311524","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604311524?lang=zh_tw&edition=fundamental","pubTime":"2026-01-20 21:30","pubTimestamp":1768915847,"startTime":"0","endTime":"0","summary":"BUZZ-治疗肺部疤痕疾病的药物获得欧盟孤儿药地位，Rein Therapeutics 股价上涨1月20日 - ** 药物开发商Rein Therapeutics RNTX.O股价盘前上涨2.5%至1.24美元 ** 该公司称 ，欧洲监管机构授予其用于治疗特发性肺纤维化的实验性疗法LTI-03孤儿药地位，IPF是一种致命的肺部疤痕疾病。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nL4T3YL1A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNTX","BK4139"],"gpt_icon":0},{"id":"1148175807","title":"Rein Therapeutics：決定終止與Yorkville於7月29日簽署的備用股權購買協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1148175807","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148175807?lang=zh_tw&edition=fundamental","pubTime":"2025-12-12 06:31","pubTimestamp":1765492294,"startTime":"0","endTime":"0","summary":"Rein Therapeutics：决定终止与Yorkville于7月29日签署的备用股权购买协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNTX"],"gpt_icon":0},{"id":"1171260931","title":"REIN THERAPEUTICS INC：決定終止與Ya Ii Pn簽訂的7月29日預付協議 - SEC備案","url":"https://stock-news.laohu8.com/highlight/detail?id=1171260931","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171260931?lang=zh_tw&edition=fundamental","pubTime":"2025-12-12 06:28","pubTimestamp":1765492092,"startTime":"0","endTime":"0","summary":"REIN THERAPEUTICS INC：决定终止与Ya Ii Pn签订的7月29日预付协议 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNTX"],"gpt_icon":0},{"id":"1137663344","title":"REIN THERAPEUTICS INC：因選擇終止Ppa和Sepa協議未產生罰款或費用","url":"https://stock-news.laohu8.com/highlight/detail?id=1137663344","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137663344?lang=zh_tw&edition=fundamental","pubTime":"2025-12-12 06:28","pubTimestamp":1765492089,"startTime":"0","endTime":"0","summary":"REIN THERAPEUTICS INC：因选择终止Ppa和Sepa协议未产生罚款或费用","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNTX"],"gpt_icon":0},{"id":"1157029139","title":"Rein Therapeutics發布新科學出版物，表明Lti-03可能減少肺部疤痕並保護肺修復所需細胞","url":"https://stock-news.laohu8.com/highlight/detail?id=1157029139","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157029139?lang=zh_tw&edition=fundamental","pubTime":"2025-11-06 20:33","pubTimestamp":1762432429,"startTime":"0","endTime":"0","summary":"Rein Therapeutics发布新科学出版物，表明Lti-03可能减少肺部疤痕并保护肺修复所需细胞。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNTX"],"gpt_icon":0},{"id":"1185602073","title":"REIN THERAPEUTICS INC獲得FDA批准恢復在美國進行Lti-03的第二階段試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1185602073","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185602073?lang=zh_tw&edition=fundamental","pubTime":"2025-11-03 20:31","pubTimestamp":1762173071,"startTime":"0","endTime":"0","summary":"REIN THERAPEUTICS INC获得FDA批准，恢复其在特发性肺纤维化（Idiopathic Pulmonary Fibrosis）领域的Lti-03的第二阶段临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNTX"],"gpt_icon":0},{"id":"1122656434","title":"Rein Therapeutics獲得歐洲監管部門批准，啓動Lti-03治療特發性肺纖維化的二期臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1122656434","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122656434?lang=zh_tw&edition=fundamental","pubTime":"2025-10-09 19:42","pubTimestamp":1760010157,"startTime":"0","endTime":"0","summary":"Rein Therapeutics获得欧洲监管部门批准，启动Lti-03治疗特发性肺纤维化的二期临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNTX","BK4139"],"gpt_icon":0},{"id":"1141656991","title":"REIN THERAPEUTICS INC - FDA建議公司提交完整回應函處理修訂研究報告及相關説明 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1141656991","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141656991?lang=zh_tw&edition=fundamental","pubTime":"2025-09-22 20:06","pubTimestamp":1758542777,"startTime":"0","endTime":"0","summary":"据向SEC提交的文件显示，FDA建议REIN THERAPEUTICS INC提交完整回应函，以处理修订后的研究报告和相关证明材料。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNTX","BK4139"],"gpt_icon":0},{"id":"1160830076","title":"REIN THERAPEUTICS INC向SEC提交招股説明書，涉及銷售股東出售最多1000萬股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1160830076","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160830076?lang=zh_tw&edition=fundamental","pubTime":"2025-09-04 06:13","pubTimestamp":1756937629,"startTime":"0","endTime":"0","summary":"REIN THERAPEUTICS INC向SEC提交招股说明书，涉及销售股东出售最多1000万股普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNTX"],"gpt_icon":0},{"id":"1177289991","title":"Rein Therapeutics向SEC提交招股説明書 擬出售多達1000萬股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1177289991","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177289991?lang=zh_tw&edition=fundamental","pubTime":"2025-09-04 05:05","pubTimestamp":1756933546,"startTime":"0","endTime":"0","summary":"Rein Therapeutics向美国证券交易委员会(SEC)提交了招股说明书，该文件涉及股东拟出售多达1000万股普通股的要约和销售事宜。\n根据SEC文件显示，此次股票出售将由现有股东进行，涉及的股票数量高达1000万股普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNTX"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}]}}